Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-03.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Seropositivity of Toxoplasmosis in Pregnant Women by ELISA at Minia University Hospital, Egypt

Seropositivity of Toxoplasmosis in Pregnant Women by ELISA at Minia University Hospital, Egypt

Article information

Korean J Parasito. 2015;53(5):605-610
Publication date (electronic) : 2015 October 29
doi : https://doi.org/10.3347/kjp.2015.53.5.605
1Department of Parasitology, Faculty of Medicine, Minia University, Minia 61519, Egypt
2Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University, Minia 61519, Egypt
3Department of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia 61519, Egypt
* Corresponding author (saraa96@yahoo.com)
Received 2015 April 13; Revised 2015 September 1; Accepted 2015 September 3.

Abstract

Toxoplasmosis is considered as an important risk factor for bad obstetric history (BOH) and one of the major causes of congenitally acquired infections. The present study aimed to estimate the seropositivity of T. gondii infection and associated risk factors among the attendees of high risk pregnancy and low risk antenatal care clinic of Minia Maternity and Pediatric University Hospital, Minia, Egypt. The study was carried out from April 2013 to April 2014 through 2 phases, the first phase was case-control study, and the second phase was follow-up with intervention. A total of 120 high risk pregnant and 120 normal pregnant females were submitted to clinical examinations, serological screening for anti-Toxoplasma IgM and IgG antibodies by ELISA, and an interview questionnaire. Seropositive cases were subjected to spiramycin course treatment. The results showed that the seroprevalence of toxoplasmosis in high-risk pregnancy group was 50.8%, which was significantly different from that of normal pregnancy group (P<0.05). Analysis of seropositive women in relation to BOH showed that abortion was the commonest form of the pregnancy wastage (56.5%). The high prevalence of T. gondii seropositive cases was observed in the age group of 21-30 years. Post-delivery adverse outcome was observed in 80.3% of high-risk pregnancy group compared to 20% of normal pregnancy group. There was a statistically significant relationship between seropositivity and living in rural area, low socioeconomic level, and undercooked meat consumption (P<0.05). Serological screening for anti-Toxoplasma antibodies should be routine tests especially among high-risk pregnant women.

INTRODUCTION

Toxoplasma gondii is one of the opportunistic obligate intracellular parasites with cats as the definitive host, while humans and animals act as intermediate hosts [1]. Human infections occur by different ways such as ingestion or handling of raw or partly cooked meat containing tissue cysts, direct contact with cats, and/or from the consumption of water or food contaminated by oocysts discharged in the feces of infected cats [2].

Congenital toxoplasmosis occurs when mother is primarily infected with T. gondii during pregnancy, and the infection spreads to the developing fetus across the placenta with possible serious problems for the fetus, including chorioretinitis, intracranial calcifications, hydrocephalus, and even stillbirth [3]. The degree of severity of the disease depends on the gestational age as severe fetal affection occurred with early gestational age infection [4].

Toxoplasmosis is considered as an important risk factor for bad obstetric outcome (BOH) and one of the major causes of congenitally acquired infections [5,6]. Therefore, early diagnosis of toxoplasmosis is a crucial step to start treatment on time to minimize the trans-placental transmission [4,7]. Toxoplasmosis is usually diagnosed by serological tests that measure Toxoplasma specific IgM and IgG antibodies [3]. The prevalence of chronic Toxoplasma infection by serological test was 64.7% in Egypt [8].

Thus, this study aimed to determine the extent of seropositivity of T. gondii infection among antenatal women with BOH and previous normal obstetric history attending antenatal care clinic of Minia Maternity and Pediatric University Hospital, Minia, Egypt. In addition to analyze the seropositivity in relation to the type of BOH and the age of the study subjects, the current study conducted to assess the outcome of current pregnancy among those with seropositivity. Also, the research aimed to correlate the seropositive patients to the demographic risk factors of T. gondii among the study groups.

MATERIALS AND METHODS

Study design and setting

This study was carried out between the period of April 2013 to April 2014 at the high risk pregnancy care clinic and the low risk antenatal care clinic of Minia Maternity and Pediatric University Hospital, Minia, Egypt.

Inclusion criteria of antenatal women of reproductive age with previous BOH (group I) was spontaneous abortion, missed abortion, intrauterine fetal death, still births, preterm deliveries, congenital malformations, perinatal death, unexplained early neonatal death, women having mentally retarded children in earlier pregnancies, and unexplained seizures. Exclusion criteria by clinical examination and laboratory investigations was other causes of fetal wastage, such as hypertension, diabetes mellitus, Rh incompatibility, physical causes of abortion, and consanguinity. Subjects with known causes of fetal wastage were excluded from the study. Normal pregnancy (group II) included multiparous age-matched antenatal women without BOH attending the same clinic.

All seropositive cases were treated with spiramycin in a dose of 3 million IU twice a day and for 2 weeks (according to the standard protocol of the Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University). Then, they were followed to assess the outcome of their pregnancy.

To work out the required sample-size for the determination of seropositivity in antenatal women with BOH, the equation suggested by Schiesselman [9] was used. Considering 46.2% seropositivity of toxoplasmosis in women with BOH [10] and 12.3% in women without BOH [4], the desired sample-size was 100 (50 cases and 50 controls). To increase the strength and consistency of the association the sample was increased, and the study was conducted among 120 cases and 120 controls.

Data collection

A structured questionnaire was used to investigate known toxoplasmosis risk factors (name, age, residential area, level of education, monthly income, contact with cats, precaution during cat feces handling, hand washing after handling raw meat, consumption of raw or undercooked meat, consumption of raw vegetables, and exposure to soil). The questionnaires were applied at face-to-face interviews by the researchers. The questions were answered orally by the participants and recorded by the researchers. The participant’s name was written on the questionnaire, so that the risk of interviewing the same patient was eliminated.

Serology

From each of the study participants, a written consent was obtained to collect 2 ml of venous blood using sterile disposable syringes under aseptic precautions. The blood samples were then transported to the Laboratory of Parasitology Department, Faculty of Medicine, Minia University, Egypt. Serum was separated from whole blood by centrifugation at 3,000 rpm for 5 min, labeled, and kept in sterile microtubes at -20˚C for further serological examinations. Each serum sample was tested for the presence of anti-Toxoplasma antibodies IgM and IgG using commercial ELISA kit (Cal Biotech Inc., Spring Valley, California, USA) following the manufacturer’s instructions. All positive cases for anti-Toxoplasma antibodies were re-tested at 3 weeks interval. The results were read by optical density at 450 nm on an ELISA reader (SLT Lab Instruments, A-5082 Grödig/Salzburg, Austria, serial no. 216692). Cut-off points and antibody index calculations were done according to manufacturers’ recommendations to categorize seropositive (antibody index >1.1), borderline positive (antibody index 0.9-1.1), and seronegative (antibody index <0.9).

Ethical approval

The study protocol was approved by the scientific ethical committee of the Department of Parasitology and the Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University at their monthly meeting on January 2013. A written informed consent was obtained from each participant.

Statistical analysis of data

Statistical analysis was done with software Statistical Package for the Social Sciences (SPSS version 17). The chi-square and Z-test (test of proportion) which is a test used for testing the significant difference between only 2 proportions were used to test statistically significant differences. The odd ratio (OR) and its 95% confidence interval (CI) were used to estimate the strength of the association between the T. gondii infection and the associated risk factors. Statistical significance was defined as a P-value of <0.05.

RESULTS

Seroprevalence of T. gondii infection in high-risk pregnancy group (group I) was 61/120 women (50.8%) vs 10/120 women (8.3%) in normal pregnancy group (group II). Seropositivity of both groups for T. gondii IgM and/or IgG antibodies was shown in Table 1 (P <0.05). Among the seropositive antenatal women with BOH, abortion was the most common form of pregnancy wastage (39 cases; 56.5%) (Table 2). The high prevalence of T. gondii seropositive cases was observed in age group of 21-30 years (Table 3). All pregnant women in this study were followed-up until delivery. Post-delivery adverse outcomes were observed in 49 cases (80.3%) and 2 cases (20%) in BOH and normal pregnancy, respectively (Table 4). Assessment of associated demographic risk factors among the seropositive cases was performed (Table 5). There was a significant T. gondii seropositivity in pregnant women living in rural area, of low socioeconomic stander, and with primary educational level, had daily contact with soil and consumed undercooked meat.

Seropositive rate of T. gondii IgM and IgG antibodies with ELISA in high risk pregnant group

Previous obstetric histories in seropositive pregnancy

Seropositive rate of T. gondii IgM and IgG antibodies in high risk pregnant group according to age

Clinical obstetric outcome(s) of seropositive pregnancy in BOH and normal pregnant groups

The correlation of demographic risk factors and T. gondii seropositivity in pregnant women

DISCUSSION

The present study showed that the seroprevalence of T. gondii infection among the high risk pregnancy group was 50.8% vs 8.3% among the normal pregnancy group. These results were in concordance with other previous studies [4,5,11]. The high seroprevalence of toxoplasmosis among pregnant females with complicated obstetric history were observed than among normal pregnant females.

Among the high risk group, 12.5% were seropositive for IgM antibodies which indicates acute infection, 32.5% were seropositive for only IgG antibodies which indicate chronic infection, and 5.8% were seropositive for both IgM and IgG antibodies which indicates possible recent infection in the last 12 months. Our results were in concordance with other many similar studies [4,6,11]. In the normal pregnancy group, 6.7% were seropositive for IgG antibodies and 1.7% were seropositive for IgM antibodies. These results agreed with El Deeb et al. [8] as they found IgG percentage higher than IgM among pregnant women in Menofia governorate, Egypt.

Abortion was the most common form of pregnancy wastage (56.5%) in our study and agreed with other reports [4,11,12]. Also, our result was similar to a previous study, a seroprevalence of 44.7% among aborted women from Qualyobia governorate, Egypt [13]. Although some reports [4,14] stated that the seropositivity of T. gondii infection increases with age; however, our results showed that the seropositivity was observed more in the age group 21-30 years, which represent the child bearing age of women. The higher seroprevalence among pregnant women aged 20-30 years were also observed [15-17].

The relationship between maternal infection with T. gondii and the post-delivery adverse pregnancy outcomes was observed in 49 cases (80.3%) and abortion was the highest risk among the adverse pregnancy outcomes. This was agreed with the meta-analysis study done by Li et al. [18]. The studies have proved that the presence of Toxoplasma cysts in chronically infected uteri lead to infection of the baby in the first trimester and often to recurrent miscarriages [19].

Treatment of a pregnant woman who acquired toxoplasmosis decreases the incidence of congenital infection by approximately 60% [7]. All seropositive cases were treated with spiramycin, and 20 cases (28.2%) gave birth to normal babies. Although spiramycin reduces the risk of placental transmission, it is not always effective [20]. Additional PCR tests for amniotic fluid are recommended for the diagnosis of toxoplasmosis.

Our study showed that living in rural area, low socio-economic stander, primary educational level, and daily contact with soil were significant risk factors for T. gondii infection. Similar results were reported in other previous studies [10,12,17]. The life style of the residents in rural areas, the presence of domestic animals as well as the favorable environmental conditions for oocysts sporulation may contribute to this significance [21]. Also, women with higher socioeconomic standers and who were highly educated adopted appropriate hygienic measures regarding food and cooking habits which tend to eradicate the sources of disease transmission [22]. Consumption of undercooked meat was also a significant risk factor. This may be attributed to the habit of eating some Egyptian food containing undercooked meat as kabbab, shawarma, Hawawshy, and luncheon.

Negative association between Toxoplasma seropositivity and some documented potential risk factors among seropositive cases in this study may suggest a limited role of these factors in Minia City, Egypt. Climate and cultural differences as regards to sanitation and food habits may contribute to this variation.

Notes

We have no conflict of interest related to this work.

References

1. Dubey JP. Toxoplasmosis of Animals and Humans Beltsville, Maryland, USA: CRC Press; 2010.
2. Torgerson PR, Mastroiacovo P. Global burden of congenital toxoplasmosis: systematic review. Bull World Health Organ 2013;91:501–508.
3. Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J Clin Microbiol 2013;51:2103–2111.
4. Sarkar MD, Anuradha B, Sharma N, Roy RN. Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India. J Health Popul Nutr 2012;30:87–92.
5. Kumari N, Morris N, Dutta R. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal. J Health Popul Nutr 2011;29:77–80.
6. Yasodhara P, Ramalakshmi BA, Lakshmi V, Krishna TP. Socioeconomic status and prevalence of toxoplasmosis during pregnancy. Indian J Med Microbiol 2004;22:241–243.
7. McLeod R, Remington JS. Toxoplasmosis (Toxoplasma gondii). In : Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics 16th edth ed. Philadelphia, Pennsylvania, USA: WB Saunders; 2000. p. 1054–1062.
8. El Deeb HK, Salah-Eldin H, Khodeer S. Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia governorate, Egypt. Acta Trop 2012;124:185–191.
9. Schiesselman JJ. Case-Control studies. Design, Conduct, Analysis New York, USA: Oxford University Press; 1982. p. 1–354.
10. Tammam AE, Haridy MA, Abdellah AH, Ahmed SR, Fayed HM, AL Sammani MA. Seroepidemiology of Toxoplasma gondii infection in women with first trimester spontaneous miscarriage in Qena governorate, Egypt. J Clin Diagn Res 2013;7:2870–2873.
11. Chintapally S. Seroprevalence of toxoplasmosis in antenatal women with bad obstetric history. Trop Parasitol 2013;3:62–66.
12. Senthamarai S, Sivasankari S, Apurba SS, Sandhya BK, Kumudavathi MS, Anitha C, Amshavathani SK. Seroprevalence of toxoplasmosis in pregnant women with bad obstetric history in a tertiary care hospital, Kanchipuram-a pilot study. Disease 2013;3:29–32.
13. Hussein AH, Ali AE, Saleh MH, Nagaty IM, Rezk AY. Seroprevalence of Toxoplasma infection in Qualyobia governorate, Egypt. J Egypt Soc Parasitol 2001;31:355–363.
14. Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, Zeynudin A. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, south western Ethiopia. BMC Infect Dis 2012;12:337.
15. Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC. Serological screening and toxoplasmosis exposure factors among pregnant women in south of Brazil. Rev Soc Bras Med Trop 2005;38:173–177.
16. Malarvizhi A, Viswanathan T, Lavanya V, Arul Sheeba Malar S, Moorthy K. Seroprevalence of Toxoplasma gondii in pregnant women. J Public Health Epidemiol 2012;4:170–177.
17. Siddiqui N, Shujatullah F, Khan HM, Rabbani T, Khan PA. Socioeconomic status and prevalence of toxoplasmosis in pregnant women with bad obstetric history. J Immunol Vaccine Technol 2014;1:101–103.
18. Li XL, Wei HX, Zhang H, Peng HJ, Lindsay DS. A meta-analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One 2014;9e97775.
19. Ajayi GO, Omilabu SA. Prenatal diagnosis of cytomegalovirus (CMV), rubella, toxoplasmosis, varicella, parvovirus, herpes simplex and syphilis. The lagos programme experience. Clin Exp Obstet Gynecol 2010;37:37–38.
20. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, ; for the European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010;7e1000351.
21. Liu Q, Wei F, Gao S, Jiang L, Yuan B, Yuan Z, Xia Z, Liu B, Xu X, Zhu XQ. Toxoplasma gondii infection in pregnant women in China. Trans R Soc Trop Med Hyg 2009;103:162–166.
22. Mohammed TK. Seroprevalence of Toxoplasma gondii among pregnant women in Baghdad city. Iraq Acad Sci J 2011;24:21–28.

Article information Continued

Table 1.

Seropositive rate of T. gondii IgM and IgG antibodies with ELISA in high risk pregnant group

Pregnant women No. of positive T. gondii Abs
P-value
IgM positive (%) IgG positive (%) Both positive (%) Total (%)
Group I (120)a 22 (18.3)c 46 (38.3)d 7 (5.83) 61 (50.83) 0.001
Group II (120)b 2 (1.66) 8 (6.66) 0 (0) 10 (8.3)
a

High risk pregnancy group.

b

Normal pregnancy group.

c

IgM positive (IgM+ combined IgM and IgG).

d

IgG positive (IgG+ combined IgM and IgG).

Table 2.

Previous obstetric histories in seropositive pregnancy

Type of previous BOH No. of subtotal No. of positive T. gondii antibodies (%)
Early embryonic pregnancy lossa 40 21 (52.5)
Late abortion (12-24) weeksa 29 18 (62.0)
Still birth (IUFD) delivery (24-40) 24 11 (45.8)
Preterm labor 15 7 (46.6)
Un-explained neonatal death 8 3 (37.5)
Congenital anomalies 4 1 (25.0)
Total cases 120 61 (50.83)
a

Abortion (early embryonic loss+late abortion).

Table 3.

Seropositive rate of T. gondii IgM and IgG antibodies in high risk pregnant group according to age

Age group Group I
Group II
P-valuea
No. of subtotal No. of positive T. gondii Abs (%) No. of subtotal No. of positive T. gondii Abs (%)
18-20 17 5 (29.4) 15 0 (0) 0.02a
21-25 41 25 (60.9) 36 4 (11.1) 0.005a
26-30 22 14 (63.6) 24 3 (12.5) 0.001a
31-35 27 12 (44.4) 28 2 (7.1) 0.007a
36-40 10 4 (40) 12 1 (8.3) 0.03a
> 40 3 1 (33.3) 5 0 (0) 0.03a
Total cases 120 61 (50.8) 120 10 (8.3)
a

P-value was calculated by Z-test (test of proportion).

Table 4.

Clinical obstetric outcome(s) of seropositive pregnancy in BOH and normal pregnant groups

Clinical obstetrics outcome No. of positive T. gondii Abs
P-valuea
Group I
Group II
No. of subtotal IgM (%) IgG (%) Both (%) No. of subtotal IgM (%) IgG (%) Both (%)
Abortion 18 8 (44.4) 6 (33.3) 4 (22.2) 1 1 (100) 0 (0) 0 (0) 0.09
Stillbirth (IUFD) 16 3 (18.8) 12 (75.0) 1 (6.3) 0 0 (0) 0 (0) 0 (0) 0.03a
Preterm labor 13 1 (7.6) 12 (92.0) 0 (0.0) 1 0 (0) 1 (100) 0 (0) 0.2
Congenital anomalies 2 1 (50.0) 0 (0.0) 1 (50.0) 0 0 (0) 0 (0) 0 (0) 0.3
Normal baby 12 2 (16.6) 9 (75.0) 1 (8.3) 8 1 (12.5) 7 (87.5) 0 (0) 0.001a
Total 61 10

P-value was calculated by comparison between IgM, IgG and both between Group I and Group II at each obstetric outcome.

a

P-value was calculated by the Fisher’s exact test.

Table 5.

The correlation of demographic risk factors and T. gondii seropositivity in pregnant women

Demographic Characterization No. of positive T. gondii Abs (%) No. of negative T. gondii Abs (%) OR (95% CI) P-value
Residence:
 Rural 42 (59.2) 73 (43.2) 1.9 (1.08-3.3) 0.02
 Urban 29 (40.8) 96 (56.8)
Education level:
 Illiterate 2 (2.8) 7 (4.1) 0.68 (0.48-0.97) 0.03
 Primary 38 (53) 29 (17.2)
 Secondary 19 (26.8) 75 (44.4)
 University 12 (16.9) 58 (34.3)
Occupation
 House wives 44 (62) 87 (51.5) 1.5 (0.87-2.7) 0.1
 Others 27 (38) 82 (48.5)
Socio-economic level
 Low 39 (54.9) 34 (20.1) 4.8 (2.6-8.8) 0.001
 Middle 29 (40.8) 102 (60.4)
 High 3 (4.2) 33 (19.5)
Contact with soil
 Yes 38 (53.5) 64 (37.9) 1.8 (1.1-3.3) 0.02
 No 33 (46.5) 105 (62.1)
Contact with cats
 Yes 10 (14.1) 11 (6.5) 2.3 (0.9-5.8) 0.06
 No 61 (85.9) 158 (93.5)
Consumption of under-cooked meat
 Yes 49 (69) 62 (36.7) 3.8 (2.1-6.9) 0.001
 No 22 (31) 107 (63.3)
Consumption of row vegetables
 Yes 71 (100) 169 (100) - -
 No 0 (0) 0 (0)
Total 71 (100) 169 (100)

P-value <0.05.

OR, odds ratio; CI, confidence interval.